CardiAMP™ Heart Failure Trial


The purpose of this study is to examine if an investigational procedure can correct the parts of the heart muscle that are not working properly due to a previous heart attack. CardiAMP is the first comprehensive therapeutic treatment utilizing a patient's own cells for the treatment of ischemic systolic heart failure, which is heart failure that develops after a heart attack


  • Approximately 7 study visits over 2 years
  • Visits may include bone marrow sampling, physical exam, electrocardiogram


  • 21-90 years old
  • Heart failure
For additional eligibility criteria please contact the study team.


18 to 65
65 and over



Monetary compensation


Can be done from home



Heart failure - overview, Heart Failure, Cardiomyopathy, bone marrow, Ischemic cardiomyopathy

Principal Investigator

Carl Pepine, MD


Division of Cardiology

Contact Information

(352) 273-8933

Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams